Research Article
Electroacupuncture Alleviates Pain Responses and Inflammation in a Rat Model of Acute Gout Arthritis
Table 1
Summary of the drugs used in the present study and the citations for their usage.
| Action | Target | Name | Abbreviation | In vivo dosage | Reference |
| Antagonist | Opioid receptors | Naloxone | NALX | 2 mg/kg (i.p.) 40 µg/ankle (i.a.) | [31] | µ-Opioid receptor | β-Funaltrexamine | β-FNLT | 50 µg/ankle (i.a.) | [32] | κ-Opioid receptor | Nor-binaltorphimine | Nor-BNI | 76 µg/ankle (i.a.) | [32] | σ-Opioid receptor | Naltrindole | NLTD | 48.7 µg/ankle (i.a.) | [32] | A1 receptor COX | KW-3902 Indomethacin | — Indo | 600 µg/ankle (i.a.) 5 mg/kg (i.p.) | [12] [35] |
| Agonist | µ-Opioid receptor | DAMGO | — | 4.9 µg/ankle (i.a.) | [34] | κ-Opioid receptor | (±) U50488 | — | 1 µg/ankle (i.a.) | [33] |
|
|